For many years, the discipline of drug formulation has been a pillar of the pharmaceutical business.
The US Food and Drug Administration (FDA) has released new draft recommendations to help sponsors develop therapies for stimulant use disorders. When it is completed, the guidance, Stimulant Use Disorders: Developing Drugs for Treatment, will be...
Sanofi and Teva Pharmaceuticals, a US division of Teva Pharmaceutical Industries Ltd., announce a partnership to co-develop and co-commercialize TEV'574, an inflammatory bowel disease treatment drug currently undergoing phase 2b clinical trials...
Amber Implants, a cutting-edge medical technology firm producing next-generation spinal implants, has announced the formal commencement of clinical trials for the VCFix Spinal System. This first-in-human clinical trial will evaluate the safety and...
Alembic Pharmaceuticals Limited stated that six of its abbreviated new drug applications (ANDA) were approved by the US Food and Drug Administration (US FDA) during Q2FY24. The company has received six...
Sanofi has announced a deal with Janssen Pharmaceuticals, Inc, a Johnson & Johnson business, to develop and commercialize Janssen's vaccine candidate for extraintestinal pathogenic E. coli (9-valent), which is now in phase 3. The deal combines...
Strides Pharma Science Ltd said that its step-down wholly-owned subsidiary, Strides Pharma Global Pte Ltd, has gained US Food and Drug Administration (USFDA) certification for its icosapent ethyl capsules in both 0.5 gram and 1 gram forms. High...
Katalin Kariko and Drew Weissman were awarded the Nobel Prize in Medicine for their work on messenger RNA (mRNA) technology, which cleared the door for the ground-breaking Covid-19 vaccines. The pair, who had been tipped as favourites...
Geron Corporation, a late-stage clinical biopharmaceutical company, announced that the European Medicines Agency (EMA) has approved imetelstat, a first-in-class investigational telomerase inhibitor, for the treatment of transfusion-dependent...
Tofidence (tocilizumab-bavi) intravenous formulation, a biosimilar monoclonal antibody referencing Actemra, has been authorized by the US Food and Drug Administration (FDA). The intravenous formulation of Tofidence has been authorized for the...
, CDSCO.jpg)
